Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study to Evaluate Treatment of Symptomatic Anemia in Patients With Malignancies Receiving Chemo- and NeoRecormon-Therapy

NCT01809314 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01809314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01809314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study to Evaluate Treatment of Symptomatic Anemia in Patients With Malignancies Receiving Chemo- and NeoRecormon-Therapy
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
October 31, 2009
Enrollment
1,167 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

anemia